76 related articles for article (PubMed ID: 8950794)
41. Reproductive condition, glomerular adenosine diphosphatase activity, and platelet aggregation in the rat: effect of endotoxin.
Visscher CA; Faas MM; Bakker WW; Schuiling GA
Biol Reprod; 1993 Dec; 49(6):1303-9. PubMed ID: 8286612
[TBL] [Abstract][Full Text] [Related]
42. Glomerular mesangial uptake of intravenously injected colloidal carbon in the rat determined by an image analysing method: lack of influence of platelet aggregation or complement activation.
Grond J; Daha MR; Elema JD
Virchows Arch B Cell Pathol Incl Mol Pathol; 1980; 33(3):281-91. PubMed ID: 6110276
[No Abstract] [Full Text] [Related]
43. Survey of the occurrence of adenosine polyphosphatase in extracellular matrix of rat tissues. A cytochemical investigation.
Hulstaert CE; Kalicharan D; Poelstra K; Bakker WW; Hardonk MJ
Histochemistry; 1991; 96(5):441-7. PubMed ID: 1836209
[TBL] [Abstract][Full Text] [Related]
44. Role of NO in ischemia/reperfusion injury.
Salmanoglu M; Onem Y
Ren Fail; 2013; 35(3):433. PubMed ID: 23356670
[No Abstract] [Full Text] [Related]
45. Acute kidney injury: Collectin-11: a signal for complement activation.
Allison SJ
Nat Rev Nephrol; 2016 Jul; 12(7):378. PubMed ID: 27140851
[No Abstract] [Full Text] [Related]
46. The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion Injury: Erratum.
Transplantation; 2020 Apr; 104(4):e117. PubMed ID: 32224818
[No Abstract] [Full Text] [Related]
47. Carbon monoxide protects the kidney through the central circadian clock and CD39.
Correa-Costa M; Gallo D; Csizmadia E; Gomperts E; Lieberum JL; Hauser CJ; Ji X; Wang B; Câmara NOS; Robson SC; Otterbein LE
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2302-E2310. PubMed ID: 29463714
[TBL] [Abstract][Full Text] [Related]
48. Regulation of the T Cell Response by CD39.
Takenaka MC; Robson S; Quintana FJ
Trends Immunol; 2016 Jul; 37(7):427-439. PubMed ID: 27236363
[TBL] [Abstract][Full Text] [Related]
49. Human recombinant apyrase therapy protects against canine pulmonary ischemia-reperfusion injury.
Ibrahim M; Wang X; Puyo CA; Montecalvo A; Huang HJ; Hachem RR; Andreetti C; Menna C; Chen R; Krupnick AS; Kreisel D; Rendina EA; Gelman AE
J Heart Lung Transplant; 2015 Feb; 34(2):247-53. PubMed ID: 25455749
[TBL] [Abstract][Full Text] [Related]
50. Loss of ectonucleotidases from the coronary vascular bed after ischemia-reperfusion in isolated rat heart.
Takahashi-Sato K; Murakawa M; Kimura J; Ito MA; Matsuoka I
BMC Cardiovasc Disord; 2013 Jul; 13():53. PubMed ID: 23890190
[TBL] [Abstract][Full Text] [Related]
51. Piracetam prevents scopolamine-induced memory impairment and decrease of NTPDase, 5'-nucleotidase and adenosine deaminase activities.
Marisco PC; Carvalho FB; Rosa MM; Girardi BA; Gutierres JM; Jaques JA; Salla AP; Pimentel VC; Schetinger MR; Leal DB; Mello CF; Rubin MA
Neurochem Res; 2013 Aug; 38(8):1704-14. PubMed ID: 23677777
[TBL] [Abstract][Full Text] [Related]
52. Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury.
Bönner F; Borg N; Burghoff S; Schrader J
PLoS One; 2012; 7(4):e34730. PubMed ID: 22514659
[TBL] [Abstract][Full Text] [Related]
53. Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia.
Sun X; Imai M; Nowak-Machen M; Guckelberger O; Enjyoji K; Wu Y; Khalpey Z; Berberat P; Munasinghe J; Robson SC
Purinergic Signal; 2011 Dec; 7(4):427-34. PubMed ID: 21656186
[TBL] [Abstract][Full Text] [Related]
54. Ectonucleotidases in the kidney.
Shirley DG; Vekaria RM; Sévigny J
Purinergic Signal; 2009 Dec; 5(4):501-11. PubMed ID: 19333785
[TBL] [Abstract][Full Text] [Related]
55. Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in mice.
Behdad A; Sun X; Khalpey Z; Enjyoji K; Wink M; Wu Y; Usheva A; Robson SC
Purinergic Signal; 2009 Sep; 5(3):335-42. PubMed ID: 19308674
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty.
Koziak K; Bojakowska M; Robson SC; Bojakowski K; Soin J; Csizmadia E; Religa P; Gaciong Z; Kaczmarek E
J Thromb Haemost; 2008 Jul; 6(7):1191-7. PubMed ID: 18485080
[TBL] [Abstract][Full Text] [Related]
57. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance.
Robson SC; Sévigny J; Zimmermann H
Purinergic Signal; 2006 Jun; 2(2):409-30. PubMed ID: 18404480
[TBL] [Abstract][Full Text] [Related]
58. E-NTPDases in human airways: Regulation and relevance for chronic lung diseases.
Burch LH; Picher M
Purinergic Signal; 2006 Jun; 2(2):399-408. PubMed ID: 18404479
[TBL] [Abstract][Full Text] [Related]
59. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
[TBL] [Abstract][Full Text] [Related]
60. Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions.
Candinas D; Koyamada N; Miyatake T; Siegel J; Hancock WW; Bach FH; Robson SC
Thromb Haemost; 1996 Nov; 76(5):807-12. PubMed ID: 8950794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
